Gapicomine

Source: Wikipedia, the free encyclopedia.
Gapicomine
Clinical data
Routes of
administration		By mouth (tablet)
ATC code
  • none
Legal status
Legal status
  • off market (was used in EU countries)
Identifiers
  • 1-Pyridin-4-yl-N-(pyridin-4-ylmethyl)methanamine
JSmol)
  • n1ccc(cc1)CNCc2ccncc2
  • InChI=1S/C12H13N3/c1-5-13-6-2-11(1)9-15-10-12-3-7-14-8-4-12/h1-8,15H,9-10H2 ☒N
  • Key:AUQQZPGNRKTPSQ-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Gapicomine (

vasodilator. It has been withdrawn from the market in the countries it was used in.[1]

Also, gapicomine is a major component in the drug Bicordin.[2]

History

Gapicomine was discovered in 1970 by Polish chemist Stanisław Biniecki. It was first published about in an article of The Polish Journal of Medicine and Pharmacy describing the derivative drug Bicordin in 1974.[3]

Synthesis

Patent:[4]

The oxime formation between isonicotinaldehyde [872-85-5] (1) and hydroxylamine gives 4-Pyridinealdoxime [696-54-8] (2). This is then reduced by catalytic hydrogenation over Raney-Nickel into 4-Picolylamine [3731-53-1] (3). Reductive amination of the last with a second equivalent of isonicotinaldehyde affords gapicomine (4).

References

  1. ^ "Gapicomine Monograph, The Index Nominum". Retrieved 2008-03-31.
  2. ^ "Bicordin, PubChem". Retrieved 2008-03-31.
  3. PMID 4453155
    .
  4. ^ Anon., GB 1058356  (1967 to Starogardzkie Zakl Farma).


cardiovascular system is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Gapicomine&oldid=1148238405"